Clinical effects of apatinib mesylate for treatment of multiple brain micrometastases: Two case reports.BACKGROUND
 Apatinib is a small-molecule multitargeted tyrosine kinase inhibitor.  Apatinib has demonstrated encouraging antitumor activities.  This study aimed to observe the efficacy and safety of apatinib for the treatment of multiple brain micrometastases.


 When the patients took 250 mg/d apatinib orally, the intracerebral lesions disappeared.  Apatinib has clear efficacy and good tolerance in patients with multiple brain micrometastases after failure of second-line treatment.
apatinib
Clinical effects of apatinib mesylate for treatment of multiple brain micrometastases: Two case reports.BACKGROUND
 Apatinib is a small-molecule multitargeted tyrosine kinase inhibitor.  Apatinib has demonstrated encouraging antitumor activities.  This study aimed to observe the efficacy and safety of apatinib for the treatment of multiple brain micrometastases.


 When the patients took 250 mg/d apatinib orally, the intracerebral lesions disappeared.  Apatinib has clear efficacy and good tolerance in patients with multiple brain micrometastases after failure of second-line treatment.
apatinib
Clinical effects of apatinib mesylate for treatment of multiple brain micrometastases: Two case reports.BACKGROUND
 Apatinib is a small-molecule multitargeted tyrosine kinase inhibitor.  Apatinib has demonstrated encouraging antitumor activities.  This study aimed to observe the efficacy and safety of apatinib for the treatment of multiple brain micrometastases.


 When the patients took 250 mg/d apatinib orally, the intracerebral lesions disappeared.  Apatinib has clear efficacy and good tolerance in patients with multiple brain micrometastases after failure of second-line treatment.
apatinib